Literature DB >> 28724662

The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus.

Elisabeth Hodille1, Warren Rose2, Binh An Diep3, Sylvain Goutelle4, Gerard Lina1, Oana Dumitrescu5.   

Abstract

Staphylococcus aureus is often involved in severe infections, in which the effects of bacterial virulence factors have great importance. Antistaphylococcal regimens should take into account the different effects of antibacterial agents on the expression of virulence factors and on the host's immune response. A PubMed literature search was performed to select relevant articles on the effects of antibiotics on staphylococcal toxin production and on the host immune response. Information was sorted according to the methods used for data acquisition (bacterial strains, growth models, and antibiotic concentrations) and the assays used for readout generation. The reported mechanisms underlying S. aureus virulence modulation by antibiotics were reviewed. The relevance of in vitro observations is discussed in relation to animal model data and to clinical evidence extracted from case reports and recommendations on the management of toxin-related staphylococcal diseases. Most in vitro data point to a decreased level of virulence expression upon treatment with ribosomally active antibiotics (linezolid and clindamycin), while cell wall-active antibiotics (beta-lactams) mainly increase exotoxin production. In vivo studies confirmed the suppressive effect of clindamycin and linezolid on virulence expression, supporting their utilization as a valuable management strategy to improve patient outcomes in cases of toxin-associated staphylococcal disease.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Staphylococcus aureus; antimicrobial agents; virulence factors

Mesh:

Substances:

Year:  2017        PMID: 28724662      PMCID: PMC5608880          DOI: 10.1128/CMR.00120-16

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  164 in total

1.  Reduction in cytokine release from human monocytes by modifications in cell wall structure of Staphylococcus aureus induced by subinhibitory concentrations of oxacillin.

Authors:  F J Schmitz; J Verhoef; U Hadding; H P Heinz; M E Jones
Journal:  J Med Microbiol       Date:  1998-06       Impact factor: 2.472

2.  Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

Authors:  Richard G Wunderink; Michael S Niederman; Marin H Kollef; Andrew F Shorr; Mark J Kunkel; Alice Baruch; William T McGee; Arlene Reisman; Jean Chastre
Journal:  Clin Infect Dis       Date:  2012-01-12       Impact factor: 9.079

3.  Two compartment kinetic model with multiple artificial capillary units.

Authors:  J Blaser; B B Stone; S H Zinner
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

4.  Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cells.

Authors:  Alvaro Pascual; Sofía Ballesta; Isabel García; Evelio J Perea
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin.

Authors:  Binh An Diep; Vien T M Le; Zehra C Visram; Harald Rouha; Lukas Stulik; Etyene Castro Dip; Gábor Nagy; Eszter Nagy
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

6.  Effect of ciprofloxacin and ofloxacin on human polymorphonuclear leukocyte activity against staphylococci.

Authors:  A Pascual; L Martínez-Martínez; E J Perea
Journal:  Chemotherapy       Date:  1989       Impact factor: 2.544

7.  Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro.

Authors:  Valérie Gauduchon; Gregoire Cozon; François Vandenesch; Anne-Laure Genestier; Nathalie Eyssade; Simone Peyrol; Jerome Etienne; Gerard Lina
Journal:  J Infect Dis       Date:  2004-01-09       Impact factor: 5.226

8.  Effect of linezolid on the phagocytic functions of human polymorphonuclear leukocytes.

Authors:  Sofía Ballesta; Alvaro Pascual; Isabel García; Evelio J Perea
Journal:  Chemotherapy       Date:  2003-07       Impact factor: 2.544

9.  Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms.

Authors:  S A Sonstein; J C Burnham
Journal:  Diagn Microbiol Infect Dis       Date:  1993 May-Jun       Impact factor: 2.803

10.  The staphylococcal saeRS system coordinates environmental signals with agr quorum sensing.

Authors:  Richard P Novick; Dunrong Jiang
Journal:  Microbiology       Date:  2003-10       Impact factor: 2.777

View more
  34 in total

Review 1.  The Great ESKAPE: Exploring the Crossroads of Bile and Antibiotic Resistance in Bacterial Pathogens.

Authors:  Kevin S Gipson; Kourtney P Nickerson; Eliana Drenkard; Alejandro Llanos-Chea; Snaha Krishna Dogiparthi; Bernard B Lanter; Rhianna M Hibbler; Lael M Yonker; Bryan P Hurley; Christina S Faherty
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

2.  Spa type distribution in MRSA and MSSA bacteremias and association of spa clonal complexes with the clinical characteristics of bacteremia.

Authors:  Elina Jokinen; Laura Lindholm; Reetta Huttunen; Heini Huhtala; Risto Vuento; Jaana Vuopio; Jaana Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-10       Impact factor: 3.267

Review 3.  Regulation of virulence and antibiotic resistance in Gram-positive microbes in response to cell wall-active antibiotics.

Authors:  Jessica J Evans; Devin D Bolz
Journal:  Curr Opin Infect Dis       Date:  2019-06       Impact factor: 4.915

4.  Analysis of Staphylococcus aureus Transcriptome in Pediatric Soft Tissue Abscesses and Comparison to Murine Infections.

Authors:  C Stamoulis; R Malley; K Moffitt; E Cheung; T Yeung
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

5.  Clindamycin suppresses virulence expression in inducible clindamycin-resistant Staphylococcus aureus strains.

Authors:  Elisabeth Hodille; Cédric Badiou; Caroline Bouveyron; Michèle Bes; Anne Tristan; François Vandenesch; Gérard Lina; Oana Dumitrescu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-10-20       Impact factor: 3.944

6.  Antimicrobial Effects of Sulfonyl Derivative of 2(5H)-Furanone against Planktonic and Biofilm Associated Methicillin-Resistant and -Susceptible Staphylococcus aureus.

Authors:  Irshad S Sharafutdinov; Elena Y Trizna; Diana R Baidamshina; Maria N Ryzhikova; Regina R Sibgatullina; Alsu M Khabibrakhmanova; Liliya Z Latypova; Almira R Kurbangalieva; Elvira V Rozhina; Mareike Klinger-Strobel; Rawil F Fakhrullin; Mathias W Pletz; Mikhail I Bogachev; Airat R Kayumov; Oliwia Makarewicz
Journal:  Front Microbiol       Date:  2017-11-20       Impact factor: 5.640

7.  Autoregulation and Virulence Control by the Toxin-Antitoxin System SavRS in Staphylococcus aureus.

Authors:  Wen Wen; Banghui Liu; Lu Xue; Zhongliang Zhu; Liwen Niu; Baolin Sun
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

8.  Antibiotic Regimens and Associated Outcomes in Children Hospitalized With Staphylococcal Scalded Skin Syndrome.

Authors:  Hannah C Neubauer; Matthew Hall; Michelle A Lopez; Andrea T Cruz; Mary Ann Queen; Dana M Foradori; Paul L Aronson; Jessica L Markham; Jennifer A Nead; Gabrielle Z Hester; Russell J McCulloh; Sowdhamini S Wallace
Journal:  J Hosp Med       Date:  2021-03       Impact factor: 2.960

Review 9.  Virulence alterations in staphylococcus aureus upon treatment with the sub-inhibitory concentrations of antibiotics.

Authors:  Juan Chen; Huyue Zhou; Jingbin Huang; Rong Zhang; Xiancai Rao
Journal:  J Adv Res       Date:  2021-01-23       Impact factor: 10.479

10.  Influence of sub-inhibitory concentrations of antimicrobials on micrococcal nuclease and biofilm formation in Staphylococcus aureus.

Authors:  Colin W K Rosman; Henny C van der Mei; Jelmer Sjollema
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.